Troy Ignelzi
2019 - Karuna Therapeutics
In 2019, Troy Ignelzi earned a total compensation of $941.9K as Chief Financial Officer at Karuna Therapeutics.
Compensation breakdown
| Bonus | $3,000 |
|---|---|
| Non-Equity Incentive Plan | $213,333 |
| Option Awards | $278,820 |
| Salary | $333,333 |
| Other | $113,413 |
| Total | $941,899 |
Ignelzi received $333.3K in salary, accounting for 35% of the total pay in 2019.
Ignelzi also received $3K in bonus, $213.3K in non-equity incentive plan, $278.8K in option awards and $113.4K in other compensation.
Rankings
In 2019, Troy Ignelzi's compensation ranked 9,546th out of 13,971 executives tracked by ExecPay. In other words, Ignelzi earned more than 31.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,546 out of 13,971 | 32nd |
Division Manufacturing | 3,836 out of 5,695 | 33rd |
Major group Chemicals And Allied Products | 1,455 out of 2,194 | 34th |
Industry group Drugs | 1,242 out of 1,880 | 34th |
Industry Pharmaceutical Preparations | 922 out of 1,392 | 34th |
Source: SEC filing on April 29, 2020.
Ignelzi's colleagues
We found three more compensation records of executives who worked with Troy Ignelzi at Karuna Therapeutics in 2019.
News
Karuna Therapeutics CEO Steven Paul's 2021 pay jumps 48% to $13M
April 27, 2022
Karuna Therapeutics CEO Steven Paul's 2020 pay slips 11% to $8.9M
April 27, 2021
Karuna Therapeutics CEO Steven Paul's 2019 pay jumps 932% to $10M
April 29, 2020
scPharmaceuticals CEO John Tucker's 2019 pay slips 17% to $1.2M
April 27, 2020
scPharmaceuticals CEO John Tucker's 2018 pay falls 25% to $1.5M
April 30, 2019